Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Lung Biotechnology PBC
Information provided by (Responsible Party):
ronald oudiz, m.d., Los Angeles Biomedical Research Institute
ClinicalTrials.gov Identifier:
NCT01966302
First received: October 15, 2013
Last updated: September 7, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)